Vascular News and Research

RSS

New molecular marker of gastric cancer

Gastric cancer (GC) is one of the most common malignancies in the world with a high incidence and death rate.

30 Mar 2009

Corthera's Relaxin in acute heart failure shows promising results

Corthera Inc. has announced that results from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, placebo-controlled international study, demonstrated promising efficacy and safety for relaxin, the company's investigational drug for treatment of acute heart failure (AHF).

30 Mar 2009

Angiogenesis inhibitor improves glioblastoma survival by reducing edema

The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (MGH) researchers.

30 Mar 2009

New evidence supports use of catheter-based therapy to remove blood clots in stroke patients

Nearly 90 percent of the 700,000 strokes that affect U.S. patients each year are caused by a blockage of blood vessels supplying the brain, known as ischemic stroke.

29 Mar 2009

Simple, noninvasive finger sensor test predicts major cardiac events

Results of a Mayo Clinic study show that a simple, noninvasive finger sensor test is "highly predictive" of a major cardiac event, such as a heart attack or stroke, for people who are considered at low or moderate risk, according to researchers.

26 Mar 2009

Gilead commences phase II trial of Cicletanine for pulmonary arterial hypertension

Gilead Sciences, Inc. has announced that it has begun enrolling patients in a Phase II clinical trial of cicletanine hydrochloride (cicletanine), an oral agent in development for the treatment of pulmonary arterial hypertension (PAH).

24 Mar 2009

New therapeutic approaches to castrate resistant prostate cancer

Today Dr. Martin Gleave of the Vancouver Prostate Centre in Canada gave a lecture about new approaches to treat castrate-resistant prostate cancer (CRCP) during the 24 th Annual Congress of the European Association of Urology in Stockholm, Sweden.

22 Mar 2009

New camera images blood circulation in real time

Burns or other disorders that disrupt the blood flow in tissues will soon be easier to assess thanks to a camera that is capable of imaging blood circulation in real time.

20 Mar 2009

Millions could benefit from statins to prevent heart attacks, strokes

Millions more patients could benefit from taking statins, drugs typically used to prevent heart attacks and strokes, than current prescribing guidelines suggest, Johns Hopkins doctors report in a new study.

19 Mar 2009

A silicone ear

To look at Matthew Houdek, you could never tell he was born with virtually no left ear.

17 Mar 2009

Drug pactimibe does not appear to reduce progression of atherosclerosis

Compared to placebo, the drug pactimibe did not effect certain measures of atherosclerosis for patients with familial hypercholesterolemia (high cholesterol levels), but these patients did have an increased incidence of cardiovascular events such as heart attack and stroke, according to a study in the March 18 issue of JAMA.

17 Mar 2009

Set of criteria help identify candidates for combined heart and kidney transplants

Researchers have identified a set of criteria that, when combined with a measure of kidney function, could help identify patients who are likely to receive a survival benefit from a combined heart and kidney transplant, according to a report in the March issue of Archives of Surgery.

16 Mar 2009

Male diabetics found to have lower levels of hydrogen sulfide in their blood

Hydrogen sulfide (H2S) is commonly associated with smell of rotten eggs, stink bombs and blocked drains but lower blood levels of the gas are possibly linked to cardiovascular complications in some male patients with type II diabetes, according to research recently presented by researchers at the Peninsula Medical School in the South West of England at the Annual Diabetes UK Professional Conference in Glasgow this week and published in Diabetic Medicine.

16 Mar 2009

Genetic mechanism in mole rats can be targeted in cancer research

"When we understand how the subterranean mole rat developed these mechanisms for survival, we may be able to understand why they are so destructive in humans," Prof. Aaron Avivi of the University of Haifa said.

15 Mar 2009

Simple interventions help prevent adverse cardiovascular effects caused by pollution

Diesel exhaust causes arteries to lose their flexibility. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that exposure to engine pollution resulted in arterial stiffness in a group of healthy volunteers.

15 Mar 2009

Schering-Plough's investigational oral thrombin receptor antagonist meets primary endpoint in a newly published study

Results of a Schering-Plough Corporation Phase II trial of SCH 530348, a novel oral thrombin receptor antagonist (TRA), were published today in The Lancet and demonstrated that the investigational antiplatelet compound met its primary endpoints of safety and tolerability.

12 Mar 2009

Vascular News and Research

New molecular marker of gastric cancer

Corthera's Relaxin in acute heart failure shows promising results

Angiogenesis inhibitor improves glioblastoma survival by reducing edema

New evidence supports use of catheter-based therapy to remove blood clots in stroke patients

Simple, noninvasive finger sensor test predicts major cardiac events

Gilead commences phase II trial of Cicletanine for pulmonary arterial hypertension

New therapeutic approaches to castrate resistant prostate cancer

New camera images blood circulation in real time

Millions could benefit from statins to prevent heart attacks, strokes

A silicone ear

Drug pactimibe does not appear to reduce progression of atherosclerosis

Set of criteria help identify candidates for combined heart and kidney transplants

Male diabetics found to have lower levels of hydrogen sulfide in their blood

Genetic mechanism in mole rats can be targeted in cancer research

Simple interventions help prevent adverse cardiovascular effects caused by pollution

Schering-Plough's investigational oral thrombin receptor antagonist meets primary endpoint in a newly published study

Discovery may lead to immunosuppressant drugs that have fewer adverse side effects

New measure for the malignancy of melanoma

DSM obtains exclusive world-wide license for innovative drug delivery technology

10 million people in the U.S. suffer from lower-limb peripheral arterial disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News